Next, we explored the temporal evolution of IFNy signaling, HLA class I-related APM, and cytotoxic T lymphocyte (CTL) abundance along with tumor proliferation over clinical responses of the TNBC index patient. This evidence concerns the gene ANPEP and neoplasm.